Profusa (NVACW) Equity Ratio (2021 - 2026)

Profusa (NVACW) reported Equity Ratio of 32.71 for Q1 2026, up 46.78% on a YoY basis from 22.29 in Q1 2025, and down 363.23% quarter-over-quarter from 7.06 in Q4 2025.

Profusa (NVACW) Equity Ratio (2021 - 2026) Analysis & Trends

Profusa has reported Equity Ratio for 6 years, with the latest figure at 32.71 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio rose 46.78% year-over-year to 32.71; the trailing twelve-month figure through Mar 2026 stood at 32.71 (up 46.78% YoY), and the FY2025 full-year result was 7.06, up 81.8% from the prior year.
  • Equity Ratio for Q1 2026 stood at 32.71, down from 7.06 in the prior quarter.
  • The five-year high for Equity Ratio was 0.0 in Q3 2022, with the low at 63.28 in Q2 2025.
  • Historically, Equity Ratio has averaged 15.42 across 5 years, with a median of 7.99 in 2025.
  • Annual changes were most pronounced in 2022 — Equity Ratio surged 89.61% — and 2023, when it plunged 317575.9%.
  • Profusa's Equity Ratio stood at 0.0 in 2022, then sank by 317575.9% to 10.11 in 2023, then slumped by 283.86% to 38.79 in 2024, then soared by 81.8% to 7.06 in 2025, then tumbled by 363.23% to 32.71 in 2026.
  • The last three Equity Ratio figures came in at 32.71 (Q1 2026), 7.06 (Q4 2025), and 7.99 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.47
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.50
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.54
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.42
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.29
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.67
10 Profusa - - - -32.71

Historic Data

Download Data
DateValue
Mar 31, 2026 -32.71
Dec 31, 2025 -7.06
Sep 30, 2025 -7.99
Jun 30, 2025 -63.28
Mar 31, 2025 -61.46
Dec 31, 2024 -38.79
Sep 30, 2024 -13.32
Jun 30, 2024 -13.33
Mar 31, 2024 -13.18
Dec 31, 2023 -10.11
Sep 30, 2023 -0.32
Jun 30, 2023 -0.26
Mar 31, 2023 -0.31
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 -0.01
Mar 31, 2022 -0.01
Dec 31, 2021 -0.03